Want to join the conversation?
$EXPE expects full year 2015 consolidated adjusted EBITDA growth, excluding eLong, of 12-15%. $EXPE expects a full year negative adjusted EBITDA impact from Orbitz of over $32MM, with approx. $15MM coming in 4Q15. This includes Integrator related costs and Orbitz operating results, which will be negatively impacted by purchase accounting rules.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.